August 2005 eUpdate
UCSF drug continues to fend off progression of type 1 diabetes
A publication in the June issue of the scientific journal Diabetes showed that a 2-week therapy with the drug hOKT3gamma1(Ala-Ala) continues to slow the progression of type 1 diabetes for at least two years after treatment. [more]
Diabetes Center's Dr. Matthias Hebrok to help lead international beta cell effort
Diabetes Center researcher and stem cell expert Dr. Matthias Hebrok, PhD has been picked to help lead an international “dream team” of researchers that will search for ways of coaxing beta cells to regenerate themselves. [more]
An editorial by Dr. Steve Gitelman, Director of UCSF's Pediatric Diabetes Program discusses where he believes the cure for diabetes will be found. [more]
Public is invited to panel on stem cell science
UCSF invites the public to attend "Stem Cell Research: Implications for the Future," a discussion among leading stem cell scientists and Nobel laureates, on Tuesday, Sept. 20, from 7:30 to 9 p.m., at UCSF’s Mission Bay campus. Reservations are required. [more]
UCSF one of top universities in NIH research funding
UCSF was the fourth largest recipient of National Institutes of Health research dollars in 2004, receiving a total of $438.8 million from all awards in the nationally competitive process, according to rankings newly released by NIH.